ISP Trademark

Trademark Overview

On Monday, August 13, 2012, a trademark application was filed for ISP with the United States Patent and Trademark Office. The USPTO has given the ISP trademark a serial number of 85702319. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 13, 2020. This trademark is owned by Immusoft Corporation. The ISP trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy products, namely, genetically engineered tissues for transplant purposes
isp

General Information

Serial Number85702319
Word MarkISP
Filing DateMonday, August 13, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 13, 2020
Registration Number4381190
Registration DateTuesday, August 6, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2013

Trademark Statements

Goods and ServicesGene therapy products, namely, genetically engineered tissues for transplant purposes
Pseudo MarkIMMUNE SYSTEM PROGRAMMING

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 13, 2020
Primary Code005
First Use Anywhere DateSaturday, August 1, 2009
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameImmusoft Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 981211172
Party NameImmusoft Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 981211172
Party NameImmusoft Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 981211172

Trademark Events

Event DateEvent Description
Friday, March 13, 2020CANCELLED SEC. 8 (6-YR)
Monday, August 6, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 6, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 1, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, July 1, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 20, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 17, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 13, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 7, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 13, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 13, 2013NON-FINAL ACTION E-MAILED
Monday, May 13, 2013SU - NON-FINAL ACTION - WRITTEN
Thursday, May 9, 2013STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 16, 2013USE AMENDMENT FILED
Wednesday, May 8, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 16, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, April 16, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 16, 2013ASSIGNED TO LIE
Wednesday, January 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 17, 2012EXAMINER'S AMENDMENT ENTERED
Monday, December 17, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 17, 2012EXAMINERS AMENDMENT E-MAILED
Monday, December 17, 2012EXAMINERS AMENDMENT -WRITTEN
Sunday, December 9, 2012ASSIGNED TO EXAMINER
Tuesday, August 21, 2012NOTICE OF PSEUDO MARK MAILED
Monday, August 20, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 16, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

tissues transplant purposes engineered genetically therapy products namely gene